Eli Lilly
3,915 hedge funds and large institutions have $610B invested in Eli Lilly in 2025 Q2 according to their latest regulatory filings, with 217 funds opening new positions, 1,780 increasing their positions, 1,451 reducing their positions, and 173 closing their positions.
32% more call options, than puts
Call options by funds: $14.1B | Put options by funds: $10.7B
25% more first-time investments, than exits
New positions opened: 217 | Existing positions closed: 173
23% more repeat investments, than reductions
Existing positions increased: 1,780 | Existing positions reduced: 1,451
0% less funds holding
Funds holding: 3,928 → 3,915 (-13)
5.56% less ownership
Funds ownership: 88.18% → 82.62% (-5.6%)
12% less capital invested
Capital invested by funds: $689B → $610B (-$79.3B)
27% less funds holding in top 10
Funds holding in top 10: 399 → 291 (-108)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$3.89B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$996M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$919M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$850M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$706M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$38.9B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.21B |
| 3 |
Primecap Management
Pasadena,
California
|
-$2.04B |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.78B |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$1.21B |
LLY Hedge Fund Activity: Q2 2025 in Review
3,915 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2025, worth a combined $610B — down 12% from $689B a quarter earlier.
Buyers outnumbered sellers: 217 funds opened new LLY positions and 173 closed out — a net gain of 44 holders — while 1,780 added to existing stakes and 1,451 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $3.89B. The largest seller was PNC Financial Services Group, cutting an estimated $38.9B.
- 3,915 institutional investors held Eli Lilly (LLY) as of Q2 2025, down from 3,928 in Q1 2025.
- Funds reported $610B of Eli Lilly stock for Q2 2025, down 12% quarter-over-quarter.
- 217 funds opened new Eli Lilly positions in Q2 2025 and 173 closed out, a net change of +44 holders.
- The largest Eli Lilly buyer in Q2 2025 was Capital Research Global Investors, an estimated $3.89B added.
- The largest Eli Lilly seller in Q2 2025 was PNC Financial Services Group, an estimated $38.9B sold.
Based on aggregated 13F filings for Q2 2025.